Given the critical role of ERK-1/-2, AKT and NF-κB signaling pathways in controlling cellular growth and survival in colorectal cancer [53,54,55], we investigated whether mertensene-induced inhibition of HT29 cell viability could modulate these proteins. The gene discussed is MAPK3; the disease is colorectal cancer.